Novo Nordisk Faces Heavy Criticism for New Campaign
Novo Nordisk faces criticism for a new campaign accused of exploiting legal gray areas and stigmatizing larger bodies. The Danish pharmaceutical giant denies hidden advertising allegations while authorities confirm campaign legality. The controversy highlights ongoing debates about pharmaceutical marketing ethics.